As CSL embarks on a restructuring drive to save more than $500 million annually over the next three years, the Australian company’s workforce reduction plans have reached one of its subsidiaries in ...
ZURICH/SYDNEY (Reuters) -Vifor Pharma's shares surged more than 15% in early trading on Monday after the Swiss drugmaker and Australia's CSL both confirmed they were talking about a potential merger.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results